Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:2090-2096
Published online before print October 2, 2003, doi: 10.1161/01.ATV.0000098653.74209.C6
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
23/11/2090    most recent
01.ATV.0000098653.74209.C6v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayek, T.
Right arrow Articles by Kaplan, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayek, T.
Right arrow Articles by Kaplan, M.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Genetically altered mice
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:2090.)
© 2003 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Tissue Angiotensin-Converting-Enzyme (ACE) Deficiency Leads to a Reduction in Oxidative Stress and in Atherosclerosis

Studies in ACE-Knockout Mice Type 2

Tony Hayek; Elsa Pavlotzky; Shadi Hamoud; Raymond Coleman; Shlomo Keidar; Michael Aviram; Marielle Kaplan

From the Lipid Research Laboratory (T.H., E.P., S.H., S.K., M.A., M.K.) and Department of Anatomy and Cell Biology (R.C.), Bruce Rappaport Faculty of Medicine, Technion, Rappaport Institute for Research in the Medical Sciences, Rambam Medical Center, Haifa, Israel.

Correspondence to Prof Tony Hayek, Internal Medicine Department E, Rambam Medical Center, 31096 Haifa, Israel. E-mail-t_hayek{at}rambam.health.gov.il

Background— Angiotensin II, produced by angiotensin-converting-enzyme (ACE), enhances oxidative stress and atherogenesis. In this study, we analyzed whether tissue ACE deficiency in ACE-knockout mice type-2 would affect their oxidative status. Moreover, by crossbreeding the ACE-knockout mice with atherosclerotic apolipoprotein E (apo E)–deficient (E0) mice, we questioned whether tissue ACE deficiency affects atherogenesis.

Methods and Results— ACE-deficient mice type-2 (ACE+/-) exhibited reduced serum lipid peroxidation compared with ACE+/+ mice. Peritoneal macrophages from ACE+/- mice demonstrated lower oxidative status, as exhibited by decreases of 47%, 33% 56%, and 51%, in their lipid peroxides, superoxide release, dichlorofluorescein fluorescence, and LDL oxidation, respectively, compared with ACE+/+ mice. ACE+/- mice crossbred with E0 mice, resulting in atherosclerotic mice heterozygous for ACE (ACE+/-/E0 mice), exhibited reduced lipid peroxidation, increased paraoxonase activity, and lower macrophage LDL oxidation compared with E0 and ACE+/+/E0 mice. ACE+/-/E0 mice also exhibited reduced NADPH-induced aortic superoxide ion production by 52% and a reduction of 43% in their atherosclerotic lesion size compared with E0 mice. Finally, 2 animals genotyped as homozygous-knockout for both ACE and APOE genes (ACE-/-/E0), exhibited a striking reduction of 86% in their atherosclerotic lesion area compared with E0 mice.

Conclusions— Reduction of tissue ACE with the ACE-knockout mouse type-2 model inhibited oxidative stress and atherogenesis.


Key Words: angiotensin-converting enzyme • atherosclerosis • knockout mice • lipoproteins




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
O. Saijonmaa, T. Nyman, and F. Fyhrquist
Atorvastatin inhibits angiotensin-converting enzyme induction in differentiating human macrophages
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1917 - H1921.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Keidar, A. Gamliel-Lazarovich, M. Kaplan, E. Pavlotzky, S. Hamoud, T. Hayek, R. Karry, and Z. Abassi
Mineralocorticoid Receptor Blocker Increases Angiotensin-Converting Enzyme 2 Activity in Congestive Heart Failure Patients
Circ. Res., October 28, 2005; 97(9): 946 - 953.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Wassmann, T. Czech, M. van Eickels, I. Fleming, M. Bohm, and G. Nickenig
Inhibition of Diet-Induced Atherosclerosis and Endothelial Dysfunction in Apolipoprotein E/Angiotensin II Type 1A Receptor Double-Knockout Mice
Circulation, November 9, 2004; 110(19): 3062 - 3067.
[Abstract] [Full Text] [PDF]